EYEN-520

N/A

Report date: 2024/09/18 10:42:20

Base Information

Drug NameEYEN-520

Drug Alias Namecombination product collaboration between Senju’s SJP-0035 formulation, fonadlepar, a peroxisome proliferator-activated receptor delta agonist for the adjunctive treatment of chronic dry eye disease, administered using the Optejet®EYEN-520

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsXerophthalmia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEyenovia Inc

China Registration ClassN/A

Develop Information

Active CompaniesEyenovia Inc

Inactive CompaniesN/A

Active IndicationsXerophthalmia

Inactive IndicationsN/A

Other Information

ATC CodeN/A